View Older Stories View More Recent Stories

Mar 31, 2017 07:03AM BioDelivery Sciences (BDSI) Announces Two New Patents Expanding Protection on BELBUCA, BUNAVAIL and ONSOLIS
Mar 31, 2017 07:00AM BioDelivery Sciences Announces the Granting of Two New Patents to be Listed in FDA's Orange Book Further Extending and Strengthening Patent Protection on BELBUCA®, BUNAVAIL® and ONSOLIS®
Mar 17, 2017 06:30AM BioDelivery Sciences Provides Corporate Update and Reports Fourth Quarter and Full-Year 2016 Financial Results
Mar 8, 2017 07:00AM BioDelivery Sciences to Present at the 29th Annual ROTH Conference
Feb 23, 2017 07:30AM BioDelivery Sciences Secures Debt Financing with CRG
Jan 9, 2017 09:45AM BioDelivery Sciences Closes Transaction to Reacquire License to BELBUCA® from Endo Pharmaceuticals
Dec 14, 2016 07:00AM BioDelivery Sciences Announces the Hiring of Peter Ginsberg as Vice President of Business Development
Dec 13, 2016 06:57AM BioDelivery Sciences (BDSI) Says Phase 2b Trial of Clonidine Topical Gel Fails to Meet its Primary Efficacy Endpoint
Dec 13, 2016 06:55AM BioDelivery Sciences Announces Clonidine Topical Gel for Painful Diabetic Neuropathy Phase 2b Trial Fails to Meet its Primary Efficacy Endpoint
Dec 8, 2016 06:03AM BioDelivery Sciences (BDSI) Announces Reacquisition of BELBUCA Rights from Endo (ENDP)
Dec 8, 2016 06:00AM BioDelivery Sciences Reacquires License to BELBUCA™ from Endo Pharmaceuticals
Nov 23, 2016 07:00AM BioDelivery Sciences to Present at the 28th Annual Piper Jaffray Healthcare Conference
Nov 9, 2016 06:00AM BioDelivery Sciences Provides Corporate Update and Reports Third Quarter 2016 Financial Results
Nov 1, 2016 07:00AM BioDelivery Sciences to Host Conference Call and Webcast Reporting Third Quarter 2016 Financial Results on Wednesday, November 9
Oct 24, 2016 07:04AM BioDelivery Sciences' (BDSI) BUNAVAIL Added to Texas Medicaid Formulary
Oct 24, 2016 07:00AM BioDelivery Sciences Announces Preferred Formulary Status for BUNAVAIL on Texas Medicaid
Oct 5, 2016 07:00AM BioDelivery Sciences Announces Additions to its Board of Directors
Sep 30, 2016 07:00AM BioDelivery Sciences Cites Impressive Number of Physicians Granted Waiver to Increase Patient Limit for Opioid Dependence Treatment Following Recent HHS Rule
Sep 23, 2016 09:13AM Pre-Open Stock Movers 09/23: (MIFI) (BATS) (TWTR) Higher; (ENPH) (IPCI) (APRI) Lower (more...)
Sep 21, 2016 07:00AM BioDelivery Sciences to Present at the Ladenburg Thalmann 2016 Healthcare Conference
Sep 19, 2016 07:00AM BioDelivery Sciences Announces Three New Managed Care Agreements; Further Enhancing Access to BUNAVAIL
Sep 6, 2016 07:00AM BioDelivery Sciences to Present at the Rodman & Renshaw 18th Annual Global Investment Conference and the 7th Annual Credit Suisse Small and Mid Cap Conference
Sep 6, 2016 07:00AM BioDelivery Sciences to Present at the Rodman & Renshaw 18th Annual Global Investment Conference and the 7th Annual Credit Suisse Small and Mid Cap Conference
Aug 10, 2016 11:59AM Streetinsider.com's Hot Lunchtime Reads 8/10: (TWTR) (FOMX) (BDSI) (HRTX)
Aug 4, 2016 07:00AM BioDelivery Sciences Announces Randomization Target Reached in Clinical Trial of Clonidine Topical Gel for the Treatment of Painful Diabetic Neuropathy
Jul 11, 2016 04:01PM BioDelivery Sciences (BDSI) Gains Preferred Formulary Status for BUNAVAIL
Jul 11, 2016 04:01PM BioDelivery Sciences Announces the Securing of Preferred Formulary Status for BUNAVAIL on a Significant Managed Care Plan
Jul 6, 2016 07:00AM BioDelivery Sciences to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
Jun 6, 2016 07:01AM BioDelivery Sciences (BDSI) Presents Data on Opioids at ASCO 2016
Jun 6, 2016 07:00AM BioDelivery Sciences Announces Presentation of Data on the Impact of a State Formulary Conversion to BUNAVAIL® at the International Conference on Opioids
Jun 6, 2016 07:00AM BioDelivery Sciences Announces Presentation of Data on the Impact of a State Formulary Conversion to BUNAVAIL® at the International Conference on Opioids
Jun 2, 2016 07:00AM BioDelivery Sciences to Present at the Jefferies 2016 Healthcare Conference
May 10, 2016 07:00AM BioDelivery Sciences Provides Corporate Update and Reports First Quarter 2016 Financial Results
May 3, 2016 07:00AM BioDelivery Sciences to Host Conference Call and Webcast of First Quarter 2016 Results on Tuesday, May 10
Apr 29, 2016 07:00AM BioDelivery Sciences Announces Acceptance of an Abstract to the International Conference on Opioids on the Impact of a State Formulary Conversion to BUNAVAIL
Mar 10, 2016 04:01PM BioDelivery Sciences Provides Corporate Update and Reports Fourth Quarter and Full-Year 2015 Financial Results
Mar 4, 2016 07:00AM BioDelivery Sciences to Present at the Cowen and Company 36th Annual Healthcare Conference and the 28th Annual ROTH Conference
Mar 3, 2016 07:00AM BioDelivery Sciences to Host Conference Call and Webcast of Fourth Quarter and Full-Year 2015 Results on Thursday, March 10
Feb 22, 2016 07:47AM BioDelivery Sciences (BDSI) Launches BELBUCA Buccal Film
Feb 22, 2016 07:45AM BioDelivery Sciences Announces the Launch of BELBUCA™ (Buprenorphine) Buccal Film by Endo Pharmaceuticals for Chronic Pain Management
Feb 18, 2016 11:34AM BioDelivery Sciences to Webcast Analyst & Investor Day on February 25th
Jan 25, 2016 10:00AM BioDelivery Sciences to Host Analyst and Investor Day on February 25th in New York City
Dec 18, 2015 10:11AM BioDelivery Sciences (BDSI) Updates on Pipeline; Has Initiated Clonidine Topical Gel Study in Diabetic Neuropathy
Dec 18, 2015 08:32AM BioDelivery Sciences Provides Pipeline Update
Dec 16, 2015 05:09PM BioDelivery Sciences Announces Organizational Changes
Dec 3, 2015 07:00AM BioDelivery Sciences Hires Joseph M. Lockhart as Vice President of Manufacturing and Supply Chain
Nov 11, 2015 07:00AM BioDelivery Sciences to Present at the Jefferies 2015 Global Healthcare Conference
Nov 9, 2015 07:00AM BioDelivery Sciences Provides Corporate Update and Reports Third Quarter 2015 Financial Results
Nov 2, 2015 07:00AM BioDelivery Sciences to Host Conference Call and Webcast of Third Quarter 2015 Results on Monday, November 9
Oct 15, 2015 07:30AM BioDelivery Sciences Announces FDA Approval of Change in BUNAVAIL® Product Specification Allowing for Immediate Release of Product
View More Recent Stories View Older Stories